Comerica Bank Harmony Biosciences Holdings, Inc. Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Comerica Bank holds 10,576 shares of HRMY stock, worth $360,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,576

Previous 11,585 8.71%

Holding current value

$360,218

Previous $349,000 20.92%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.0 - $39.95 $30,270 - $40,309	-1,009 Reduced 8.71%	10,576 $422,000
Q2 2024 Aug 15, 2024	SELL	$28.81 - $33.01 $66,896 - $76,649	-2,322 Reduced 16.7%	11,585 $349,000
Q1 2024 May 15, 2024	SELL	$29.93 - $35.06 $53,425 - $62,582	-1,785 Reduced 11.38%	13,907 $466,000
Q4 2023 Feb 14, 2024	SELL	$19.2 - $33.78 $10,502 - $18,477	-547 Reduced 3.37%	15,692 $506,000
Q3 2023 Nov 21, 2023	BUY	$31.89 - $39.03 $517,861 - $633,808	16,239 New	16,239 $532,000
Q4 2022 Jan 26, 2023	SELL	$45.4 - $60.91 $219,872 - $294,987	-4,843 Reduced 21.36%	17,826 $0
Q3 2022 Oct 28, 2022	BUY	$42.06 - $55.45 $129,334 - $170,508	3,075 Added 15.69%	22,669 $1.17 Million
Q2 2022 Aug 02, 2022	BUY	$33.54 - $52.15 $2,917 - $4,537	87 Added 0.45%	19,594 $1.03 Million
Q1 2022 Apr 27, 2022	BUY	$33.14 - $51.13 $23,529 - $36,302	710 Added 3.78%	19,507 $949,000
Q4 2021 Feb 18, 2022	SELL	$34.09 - $43.91 $2.64 Million - $3.4 Million	-77,543 Reduced 80.49%	18,797 $801,000
Q3 2021 Nov 22, 2021	BUY	$25.68 - $38.61 $2.47 Million - $3.72 Million	96,340 New	96,340 $3.69 Million

Others Institutions Holding HRMY

# of Institutions

242

Shares Held

45.1M

Call Options Held

108K

Put Options Held

49.2K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.02B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account